Related references
Note: Only part of the references are listed.Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clinical outcomes
Eric P. Hoffman et al.
STEROIDS (2018)
The chaperone co-inducer BGP-15 alleviates ventilation-induced diaphragm dysfunction
Heba Salah et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Mechanical Signaling in the Pathophysiology of Critical Illness Myopathy
Rebeca C. Kalamgi et al.
FRONTIERS IN PHYSIOLOGY (2016)
THE SICK AND THE WEAK: NEUROPATHIES/MYOPATHIES IN THE CRITICALLY ILL
O. Friedrich et al.
PHYSIOLOGICAL REVIEWS (2015)
Regulation of autophagy and the ubiquitin-proteasome system by the FoxO transcriptional network during muscle atrophy
Giulia Milan et al.
NATURE COMMUNICATIONS (2015)
VBP15, a Novel Anti-Inflammatory, is Effective at Reducing the Severity of Murine Experimental Autoimmune Encephalomyelitis
Blythe C. Dillingham et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2015)
Glucocorticoids improve high-intensity exercise performance in humans
Rafael A. Casuso et al.
EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY (2014)
Time course analysis of mechanical ventilation-induced diaphragm contractile muscle dysfunction in the rat
R. Corpeno et al.
JOURNAL OF PHYSIOLOGY-LONDON (2014)
Effects of Short-Term Dexamethasone Administration on Corticospinal Excitability
Stephane Baudry et al.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2014)
Masseter Muscle Myofibrillar Protein Synthesis and Degradation in an Experimental Critical Illness Myopathy Model
Hazem Akkad et al.
PLOS ONE (2014)
VBP15: Preclinical characterization of a novel anti-inflammatory delta 9,11 steroid
Erica K. M. Reeves et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects
Christopher R. Heier et al.
EMBO MOLECULAR MEDICINE (2013)
Glucocorticoid-induced skeletal muscle atrophy
O. Schakman et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
Sparing of muscle mass and function by passive loading in an experimental intensive care unit model
Guillaume Renaud et al.
JOURNAL OF PHYSIOLOGY-LONDON (2013)
Steroid-induced myopathy
Serge Perrot et al.
PRESSE MEDICALE (2012)
Mechanisms underlying ICU muscle wasting and effects of passive mechanical loading
Monica Llano-Diez et al.
CRITICAL CARE (2012)
Glucocorticoid-induced myopathy
Rosa Maria Rodrigues Pereira et al.
JOINT BONE SPINE (2011)
Preferential skeletal muscle myosin loss in response to mechanical silencing in a novel rat intensive care unit model: underlying mechanisms
Julien Ochala et al.
JOURNAL OF PHYSIOLOGY-LONDON (2011)
Risk factors in critical illness myopathy during the early course of critical illness: a prospective observational study
Steffen Weber-Carstens et al.
CRITICAL CARE (2010)
Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: A systematic review and meta-analysis
Benjamin M. P. Tang et al.
CRITICAL CARE MEDICINE (2009)
Mechanisms of Muscle Atrophy Induced by Glucocorticoids
O. Schakman et al.
HORMONE RESEARCH (2009)
Myofibrillar protein and gene expression in acute quadriplegic myopathy
Holly Norman et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Predisposing factors for critical illness polyneuromyopathy in a multidisciplinary intensive care unit
S. Nanas et al.
ACTA NEUROLOGICA SCANDINAVICA (2008)
Potent diuretic effects of prednisone in heart failure patients with refractory diuretic resistance
Chao Liu et al.
CANADIAN JOURNAL OF CARDIOLOGY (2007)
Transcription factors in muscle atrophy caused by blocked neuromuscular transmission and muscle unloading in rats
Jenny Nordquist et al.
MOLECULAR MEDICINE (2007)
Proteasome proteolytic activity in skeletal muscle is increased in patients with sepsis
Maria Klaude et al.
CLINICAL SCIENCE (2007)
Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome
D Annane et al.
CRITICAL CARE MEDICINE (2006)
Insulin therapy protects the central and peripheral nervous system of intensive care patients
G Van den Berghe et al.
NEUROLOGY (2005)
Critical illness polyneuropathy and myopathy in patients with acute respiratory distress syndrome
S Bercker et al.
CRITICAL CARE MEDICINE (2005)
Risk factors for critical illness polyneuromyopathy
J Bednarik et al.
JOURNAL OF NEUROLOGY (2005)
Baroreflexes of the rat. III. Open-loop gain and electroencephalographic arousal
BR Dworkin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2004)
Glucocorticoid regulation of the inflammatory response to injury
MP Yeager et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2004)
Risk factors for the development of polyneuropathy and myopathy in critically ill patients
MACJ de Letter et al.
CRITICAL CARE MEDICINE (2001)
Critical illness polyneuropathy:: risk factors and clinical consequences.: A cohort study in septic patients
J Garnacho-Montero et al.
INTENSIVE CARE MEDICINE (2001)
LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing
Y Kabeya et al.
EMBO JOURNAL (2000)
Critical illness polyneuropathy and myopathy (CIPNM):: evidence for local immune activation by cytokine-expression in the muscle tissue
MACJ De Letter et al.
JOURNAL OF NEUROIMMUNOLOGY (2000)
Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: Mechanisms at the cellular and molecular levels
L Larsson et al.
CRITICAL CARE MEDICINE (2000)
Share Paper
